These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28807730)

  • 1. Development of a dual reporter screening assay for distinguishing the inhibition of HIV Tat-mediated transcription from off-target effects.
    Shin Y; Choi BS; Kim KC; Kang C; Kim K; Yoon CH
    J Virol Methods; 2017 Nov; 249():1-9. PubMed ID: 28807730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short communication: a single step assay for rapid evaluation of inhibitors targeting HIV type 1 Tat-mediated long terminal repeat transactivation.
    Chande AG; Baba M; Mukhopadhyaya R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):902-6. PubMed ID: 21878060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tricyclo-DNA containing oligonucleotides as steric block inhibitors of human immunodeficiency virus type 1 tat-dependent trans-activation and HIV-1 infectivity.
    Ivanova G; Reigadas S; Ittig D; Arzumanov A; Andreola ML; Leumann C; Toulmé JJ; Gait MJ
    Oligonucleotides; 2007; 17(1):54-65. PubMed ID: 17461763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel compounds against Tat-mediated human immunodeficiency virus-1 transcription by high-throughput functional screening assay.
    Shin Y; Kim HG; Park CM; Choi MS; Kim DE; Choi BS; Kim K; Yoon CH
    Biochem Biophys Res Commun; 2020 Mar; 523(2):368-374. PubMed ID: 31866007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel inhibitors of human immunodeficiency virus type 1 replication by in silico screening targeting cyclin T1/Tat interaction.
    Hamasaki T; Okamoto M; Baba M
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1323-31. PubMed ID: 23274668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structure-activity study of the inhibition of HIV-1 Tat-dependent trans-activation by mixmer 2'-O-methyl oligoribonucleotides containing locked nucleic acid (LNA), alpha-L-LNA, or 2'-thio-LNA residues.
    Arzumanov A; Stetsenko DA; Malakhov AD; Reichelt S; Sørensen MD; Babu BR; Wengel J; Gait MJ
    Oligonucleotides; 2003; 13(6):435-53. PubMed ID: 15025911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to the Tat Inhibitor Didehydro-Cortistatin A Is Mediated by Heightened Basal HIV-1 Transcription.
    Mousseau G; Aneja R; Clementz MA; Mediouni S; Lima NS; Haregot A; Kessing CF; Jablonski JA; Thenin-Houssier S; Nagarsheth N; Trautmann L; Valente ST
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.
    Mousseau G; Clementz MA; Bakeman WN; Nagarsheth N; Cameron M; Shi J; Baran P; Fromentin R; Chomont N; Valente ST
    Cell Host Microbe; 2012 Jul; 12(1):97-108. PubMed ID: 22817991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simple assay system for examination of the inhibitory potential in vivo of decoy RNAs, ribozymes and other drugs by measuring the Tat-mediated transcription of a fusion gene composed of the long terminal repeat of HIV-1 and a gene for luciferase.
    Koseki S; Ohkawa J; Yamamoto R; Takebe Y; Taira K
    J Control Release; 1998 Apr; 53(1-3):159-73. PubMed ID: 9741924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.
    Lacombe B; Morel M; Margottin-Goguet F; Ramirez BC
    J Virol; 2016 Dec; 90(23):10972-10980. PubMed ID: 27681137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sensitive and versatile bioluminescence bioassay for HIV type 1 based on adenoviral vectors.
    Axelrod JH; Honigman A
    AIDS Res Hum Retroviruses; 1999 May; 15(8):759-67. PubMed ID: 10357471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel neuroprotective GSK-3β inhibitor restricts Tat-mediated HIV-1 replication.
    Guendel I; Iordanskiy S; Van Duyne R; Kehn-Hall K; Saifuddin M; Das R; Jaworski E; Sampey GC; Senina S; Shultz L; Narayanan A; Chen H; Lepene B; Zeng C; Kashanchi F
    J Virol; 2014 Jan; 88(2):1189-208. PubMed ID: 24227837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
    Zhang HS; Chen XY; Wu TC; Zhang FJ
    J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin inhibits Tat-dependent transactivation of HIV type 1 LTR.
    Jeyaseelan R; Kurabayashi M; Kedes L
    AIDS Res Hum Retroviruses; 1996 May; 12(7):569-76. PubMed ID: 8743082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent status of HIV-1 gene expression inhibitors.
    Baba M
    Antiviral Res; 2006 Sep; 71(2-3):301-6. PubMed ID: 16488488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-Phenylcoumarins as inhibitors of HIV-1 replication.
    Olmedo D; Sancho R; Bedoya LM; López-Pérez JL; Del Olmo E; Muñoz E; Alcamí J; Gupta MP; San Feliciano A
    Molecules; 2012 Aug; 17(8):9245-57. PubMed ID: 22858844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure.
    Jin H; Li D; Lin MH; Li L; Harrich D
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32276443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC1/NFκB pathway is involved in curcumin inhibiting of Tat-mediated long terminal repeat transactivation.
    Zhang HS; Ruan Z; Sang WW
    J Cell Physiol; 2011 Dec; 226(12):3385-91. PubMed ID: 21344388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.